22 Facts About Baxter International

Baxter International Inc is an American multinational healthcare company with headquarters in Deerfield, Illinois.

Baxter International was founded in 1931 by Donald Baxter, a Los Angeles-based medical doctor, as a manufacturer and distributor of intravenous therapy solutions.

Baxter International's interest was bought out in 1935 by Ralph Falk, who established a research and development function.

In 1956 Baxter International introduced the first functioning artificial kidney, and in 1971 became a member of the Fortune 500.

In 1971, Baxter International built a major manufacturing plant in Ashdod, Israel, and as a result, the company was placed on the Arab League boycott list in the early 1980s.

Related searches

In 1982, Baxter International acquired Medcom, Inc, a New York-based firm founded by Richard Fuisz and his brother, that had large markets in the United States and Saudi Arabia.

Fuisz alleged that Baxter International had sold their profitable Ashdod facility to Teva Pharmaceutical Industries in 1988 while simultaneously negotiating the construction of a similar plant in Syria in partnership with the Syrian military in order to be removed from the Arab League blacklist in 1989.

In 1993 Baxter International pleaded guilty to a felony in relation to an anti-boycott law in the United States.

Baxter International acquired medical device firm Baxa on November 10,2011.

In March 2014, Baxter International announced plans to create two separate, independent global healthcare companies—one focused on developing and marketing bio-pharmaceuticals and the other on medical products.

In December 2016, Baxter International announced it would acquire Claris Lifesciences injectables subsidiary, Claris Injectables, for $625 million.

Baxter International alumni groomed by Loucks included Terry Mulligan of MedAssets, Lance Piccolo at Caremark, Mike Mussallem of Edwards Lifesciences Corp and CEOs of Boston Scientific Corp.

Baxter International was an early joiner in the "green and greedy" movement, which aims to lessen the environmental impacts of manufacturing its products while saving the company money.

In July 2009, Baxter International announced completion of the first commercial vaccine for the H1N1 influenza.

Baxter International has been one of several working with the World Health Organization and United States Centers for Disease Control and Prevention on the vaccine, and uses a cell-based rather than egg-based technology that allows a shorter production time.

In 2008, Baxter International launched Science@Work: Expanding Minds with Real-World Science, which supports teacher training and student development in healthcare and biotechnology in Chicago Public Schools.

Baxter International was included for the 13th year in Corporate Responsibility magazine's 100 Best Corporate Citizens list in 2014 for its social responsibility performance.

Baxter International Althane disaster in autumn 2001 was a series of 56 sudden deaths of kidney failure patients in Spain, Croatia, Italy, Germany, Taiwan, Colombia and the USA.

In 2008, the quality of blood thinning products produced by Baxter International was brought into question when they were linked to 81 deaths and 785 severe allergic reactions in the United States according to the FDA.

Baxter International initiated a voluntary recall, temporarily suspended the manufacture of heparin, and launched an investigation.

In mid-January 2008 Baxter International voluntarily recalled some lots of multi-dose vials of Heparin in February in consultation with the FDA Baxter International recalled the rest of their Heparin products.

In 2010, Baxter International was ordered by the FDA to recall all of their Colleague infusion pumps from the market due to 87 recalls and deaths associated with the pump.